The National Venture Capital Assn. names the 2.3% medical device tax contained in the Affordable Care Act among its top repeal priorities, entertaining opportunities for the industry to repeal or relax the levy.
The National Venture Capital Assn. has the impending medical device tax in its cross-hairs as a top priority for take-down, according to the organization.
The 2.3% medtech tax, taking effect January 1, 2013, has long been on the group's hit-list, but the NVCA seems to have a renewed sense of urgency and momentum following the recent election. The device tax "could be looked at early in the new Congress," depending on how the legislative body handles issues such as the "fiscal cliff" before the new Congress is seated.